COVID-19 |

COVID-19

Matches in COVID-19 for { <http://dx.doi.org/10.3390%2Fph9040078> ?p ?o. }

Showing items 401 to 471 of 471 with 100 items per page.

first
previous

10.3390%2Fph9040078 wordsInBody "provided".
10.3390%2Fph9040078 wordsInBody "range".
10.3390%2Fph9040078 wordsInBody "rate".
10.3390%2Fph9040078 wordsInBody "recent".
10.3390%2Fph9040078 wordsInBody "recently".
10.3390%2Fph9040078 wordsInBody "reduced".
10.3390%2Fph9040078 wordsInBody "region".
10.3390%2Fph9040078 wordsInBody "regions".
10.3390%2Fph9040078 wordsInBody "related".
10.3390%2Fph9040078 wordsInBody "reported".
10.3390%2Fph9040078 wordsInBody "required".
10.3390%2Fph9040078 wordsInBody "research".
10.3390%2Fph9040078 wordsInBody "respectively".
10.3390%2Fph9040078 wordsInBody "respiratory".
10.3390%2Fph9040078 wordsInBody "response".
10.3390%2Fph9040078 wordsInBody "result".
10.3390%2Fph9040078 wordsInBody "resulting".
10.3390%2Fph9040078 wordsInBody "results".
10.3390%2Fph9040078 wordsInBody "revealed".
10.3390%2Fph9040078 wordsInBody "risk".
10.3390%2Fph9040078 wordsInBody "rna".
10.3390%2Fph9040078 wordsInBody "role".
10.3390%2Fph9040078 wordsInBody "sample".
10.3390%2Fph9040078 wordsInBody "samples".
10.3390%2Fph9040078 wordsInBody "selected".
10.3390%2Fph9040078 wordsInBody "sequence".
10.3390%2Fph9040078 wordsInBody "sequences".
10.3390%2Fph9040078 wordsInBody "set".
10.3390%2Fph9040078 wordsInBody "severe".
10.3390%2Fph9040078 wordsInBody "showed".
10.3390%2Fph9040078 wordsInBody "shown".
10.3390%2Fph9040078 wordsInBody "significant".
10.3390%2Fph9040078 wordsInBody "significantly".
10.3390%2Fph9040078 wordsInBody "similar".
10.3390%2Fph9040078 wordsInBody "single".
10.3390%2Fph9040078 wordsInBody "size".
10.3390%2Fph9040078 wordsInBody "small".
10.3390%2Fph9040078 wordsInBody "specific".
10.3390%2Fph9040078 wordsInBody "studies".
10.3390%2Fph9040078 wordsInBody "suggest".
10.3390%2Fph9040078 wordsInBody "suggested".
10.3390%2Fph9040078 wordsInBody "suggesting".
10.3390%2Fph9040078 wordsInBody "suggests".
10.3390%2Fph9040078 wordsInBody "syndrome".
10.3390%2Fph9040078 wordsInBody "taken".
10.3390%2Fph9040078 wordsInBody "target".
10.3390%2Fph9040078 wordsInBody "test".
10.3390%2Fph9040078 wordsInBody "tested".
10.3390%2Fph9040078 wordsInBody "time".
10.3390%2Fph9040078 wordsInBody "times".
10.3390%2Fph9040078 wordsInBody "total".
10.3390%2Fph9040078 wordsInBody "treatment".
10.3390%2Fph9040078 wordsInBody "type".
10.3390%2Fph9040078 wordsInBody "types".
10.3390%2Fph9040078 wordsInBody "use".
10.3390%2Fph9040078 wordsInBody "values".
10.3390%2Fph9040078 wordsInBody "various".
10.3390%2Fph9040078 wordsInBody "viral".
10.3390%2Fph9040078 wordsInBody "virus".
10.3390%2Fph9040078 wordsInBody "viruses".
10.3390%2Fph9040078 wordsInBody "work".
10.3390%2Fph9040078 wordsInBody "years".
10.3390%2Fph9040078 wordsInTitle "antiviral".
10.3390%2Fph9040078 wordsInTitle "human".
10.3390%2Fph9040078 wordsInTitle "viruses".
10.3390%2Fph9040078 identifier "doi:10.3390/ph9040078".
10.3390%2Fph9040078 isCitedBy 18efb24780930c0ee4343fd31b37b39ce3c3b315.
10.3390%2Fph9040078 realization 430213ca4c52874f7082c2a1d1c3117187e41dae.
10.3390%2Fph9040078 type ResearchPaper.
10.3390%2Fph9040078 type work.
10.3390%2Fph9040078 publishedBy "Pharmaceuticals (Basel)".

first
previous